Harada I, Mitsui K, Uchida K, Yamaguchi H
Teikyo University Institute of Medical Mycology.
Jpn J Antibiot. 1997 Feb;50(2):195-9.
In vitro antifungal activities of rilopirox (RIL), a new topical hydroxypyridone antifungal agent, were studied against 7 species (31 strains) of yeast-like fungi and 15 species (17 strains) of mycerial fungi from stock cultures of a wide range of medically important fungi. Tests were carried out by the liquid dilution method using Neopeptone dextrose broth with ciclopirox olamine (CPO) and oxiconazole nitrate (OCZ) as reference drugs. RIL exhibited a broad spectrum of antifungal activities; the MIC of RIL against yeasts were about 1 microgram/ml, those against other fungi were 0.5-4 micrograms/ml. Antifungal activities were similar to CPO, and compare to OCZ, RIL showed characteristically little differences in its activities against different species or strains of target organisms.
新型外用羟基吡啶酮类抗真菌药利洛吡司(RIL)对从多种具有重要医学意义真菌的保藏培养物中获取的7种(31株)酵母样真菌和15种(17株)丝状真菌进行了体外抗真菌活性研究。以环吡酮胺(CPO)和硝酸奥昔康唑(OCZ)作为参比药物,采用液体稀释法,在新胨葡萄糖肉汤中进行试验。RIL表现出广谱抗真菌活性;RIL对酵母的最低抑菌浓度约为1微克/毫升,对其他真菌的最低抑菌浓度为0.5 - 4微克/毫升。其抗真菌活性与CPO相似,与OCZ相比,RIL对不同种类或菌株的靶标生物的活性差异极小。